Cargando…

Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody

Detalles Bibliográficos
Autores principales: Gao, Han, Cai, Haiyan, Liu, Jia, Wang, Xiaoxiao, Zheng, Pan, Devenport, Martin, Xu, Ting, Dou, Fei, Liu, Yang, Zhou, Aiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606454/
https://www.ncbi.nlm.nih.gov/pubmed/33298884
http://dx.doi.org/10.1038/s41421-020-00202-9
_version_ 1783604484856872960
author Gao, Han
Cai, Haiyan
Liu, Jia
Wang, Xiaoxiao
Zheng, Pan
Devenport, Martin
Xu, Ting
Dou, Fei
Liu, Yang
Zhou, Aiwu
author_facet Gao, Han
Cai, Haiyan
Liu, Jia
Wang, Xiaoxiao
Zheng, Pan
Devenport, Martin
Xu, Ting
Dou, Fei
Liu, Yang
Zhou, Aiwu
author_sort Gao, Han
collection PubMed
description
format Online
Article
Text
id pubmed-7606454
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-76064542020-11-04 Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody Gao, Han Cai, Haiyan Liu, Jia Wang, Xiaoxiao Zheng, Pan Devenport, Martin Xu, Ting Dou, Fei Liu, Yang Zhou, Aiwu Cell Discov Correspondence Springer Singapore 2020-11-03 /pmc/articles/PMC7606454/ /pubmed/33298884 http://dx.doi.org/10.1038/s41421-020-00202-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Gao, Han
Cai, Haiyan
Liu, Jia
Wang, Xiaoxiao
Zheng, Pan
Devenport, Martin
Xu, Ting
Dou, Fei
Liu, Yang
Zhou, Aiwu
Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title_full Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title_fullStr Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title_full_unstemmed Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title_short Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
title_sort structure of ctla-4 complexed with a ph-sensitive cancer immunotherapeutic antibody
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606454/
https://www.ncbi.nlm.nih.gov/pubmed/33298884
http://dx.doi.org/10.1038/s41421-020-00202-9
work_keys_str_mv AT gaohan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT caihaiyan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT liujia structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT wangxiaoxiao structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT zhengpan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT devenportmartin structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT xuting structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT doufei structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT liuyang structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody
AT zhouaiwu structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody